Found: 29
Select item for more details and to access through your institution.
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Risk Factors for Healthcare Personnel Infection With Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT).
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4428, doi. 10.1093/cid/ciaa900
- By:
- Publication type:
- Article
Influence of Preseason Antibodies Against Influenza Virus on Risk of Influenza Infection Among Healthcare Personnel.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Preschool-Aged Household Contacts as a Risk Factor for Viral Respiratory Infections in Healthcare Personnel.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 2, p. 1, doi. 10.1093/ofid/ofad057
- By:
- Publication type:
- Article
N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effectiveness of Live, Attenuated Intranasal Influenza Virus Vaccine in Healthy, Working Adults.
- Published in:
- JAMA: Journal of the American Medical Association, 1999, v. 282, n. 2, p. 137, doi. 10.1001/jama.282.2.137
- By:
- Publication type:
- Article
Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine.
- Published in:
- Clinical Infectious Diseases, 2003, v. 36, n. 2, p. 169, doi. 10.1086/345668
- By:
- Publication type:
- Article
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 5, p. 1230
- By:
- Publication type:
- Article
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 310, doi. 10.1086/514209
- By:
- Publication type:
- Article
A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 330
- By:
- Publication type:
- Article
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 340
- By:
- Publication type:
- Article
Induction of Mucosal Antibodies by Live Attenuated and Inactivated Influenza Virus Vaccines in the Chronically III Elderly.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 285
- By:
- Publication type:
- Article
Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 4, p. 782
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection.
- Published in:
- Journal of Infectious Diseases, 1993, v. 168, n. 6, p. 1387, doi. 10.1093/infdis/168.6.1387
- By:
- Publication type:
- Article
Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults.
- Published in:
- Journal of Infectious Diseases, 1993, v. 167, n. 3, p. 533, doi. 10.1093/infdis/167.3.533
- By:
- Publication type:
- Article
Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 1992, v. 166, n. 2, p. 244, doi. 10.1093/infdis/166.2.244
- By:
- Publication type:
- Article
Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 5, p. 512, doi. 10.1002/jmv.25715
- By:
- Publication type:
- Article
Inhibition of Interferon Yield by Vincristine<sup>1</sup><sup>2</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1984, v. 175, n. 3, p. 309, doi. 10.3181/00379727-175-41800
- By:
- Publication type:
- Article
The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 2, p. 172, doi. 10.1086/599790
- By:
- Publication type:
- Article
Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals.
- Published in:
- Journal of Infectious Diseases, 2008, v. 198, n. 9, p. 1317, doi. 10.1086/592168
- By:
- Publication type:
- Article
Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 1, p. 11, doi. 10.1086/421121
- By:
- Publication type:
- Article
Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 7, p. 1221
- By:
- Publication type:
- Article
Canarypox Vaccines Induce Antigen-Specific Human gammadelta T Cells Capable of Interferon-gamma Production.
- Published in:
- Journal of Infectious Diseases, 2001, v. 184, n. 5, p. 525, doi. 10.1086/322792
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Canarypox-Vectored HIV Type 1 Vaccine with or without gp120.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 9, p. 1343
- By:
- Publication type:
- Article
Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 4, p. 1080, doi. 10.1086/314985
- By:
- Publication type:
- Article
A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8[sup+] Cytotoxic T Lymphocyte Responses in Seronegative Volunteers.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2, doi. 10.1086/314895
- By:
- Publication type:
- Article
Interpatient mutational spectrum of human coronavirus-OC43 revealed by illumina sequencing.
- Published in:
- Journal of Medical Virology, 2017, v. 89, n. 8, p. 1330, doi. 10.1002/jmv.24780
- By:
- Publication type:
- Article